| Dr Amy Hayden Ray, MD | |
|
2200 E. Parrish Ave, Bldg B, Ste 101, Owensboro, KY 42303-1449 | |
| (270) 683-3232 | |
| (270) 852-1600 |
| Full Name | Dr Amy Hayden Ray |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 2200 E. Parrish Ave, Owensboro, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003801986 | NPI | - | NPPES |
| 000000345566 | Other | KY | ID BLUE CROSS INSURANCE |
| 000000345566 | Other | BLUE CROSS | |
| 64082597 | Medicaid | KY | |
| 50006859 | Other | KY | PASSPORT NON-PARTICIPATE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 38474 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amy Hayden Ray, MD 2200 E. Parrish Ave, Bldg B, Ste 101, Owensboro, KY 42303-1449 Ph: (270) 683-3232 | Dr Amy Hayden Ray, MD 2200 E. Parrish Ave, Bldg B, Ste 101, Owensboro, KY 42303-1449 Ph: (270) 683-3232 |
News Archive
Patients with early bladder cancer who receive more intensive treatment within the first two years of diagnosis do not appear to have better survival than patients who receive less intensive treatment, according to a retrospective analysis published in the April 7 online issue of the Journal of the National Cancer Institute.
MRI scans that detect shrinkage in specific regions of the mid-brain attacked by Alzheimer's disease accurately diagnose the neurodegenerative disease, even before symptoms interfere with daily function, a study by the Florida Alzheimer's Disease Research Center (ADRC) in Miami and Tampa found.
A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with non-small cell lung cancer (NSCLC) if they have previously received radiation therapy, compared to those without a history of radiation treatment.
CANCER rates in middle-aged men and women in Great Britain have gone up by nearly 20 per cent in a generation - an increase of 17,000 cases a year - according to new figures released today (Monday) by Cancer Research UK.
Many tests for predictive biomarkers in tumors focus on selected known mutations or regions (e.g. hotspot panels). In a new study, scientists at Molecular Health examined the rates of secondary mutations in known biomarker genes and their potential impact on the diagnostic reliability of specific single-nucleotide variant (SNV) biomarker testing.
› Verified 8 days ago
Dr. Maria Elena Rivas, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1003 Burlew Blvd, Suite C, Owensboro, KY 42303 Phone: 270-683-6848 Fax: 270-685-4197 | |
Mrs. Courtney Quisenberry Crews, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2200 E Parrish Ave, Bldg B, Ste 101, Owensboro, KY 42303 Phone: 270-683-3232 Fax: 270-852-1600 | |
Dr. David Edward Danhauer, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4800 Hunters Ridge, Owensboro, KY 42303 Phone: 270-688-9067 | |
Dr. John Martin Phillips Ii, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1000 Breckenridge St Ste 300, Owensboro, KY 42303 Phone: 270-688-4480 Fax: 270-688-4489 | |
Heather J. Johnson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1201 Pleasant Valley Rd, 7th Floor, Owensboro, KY 42303 Phone: 270-417-4705 Fax: 270-417-4709 | |
Jeremiah Robert Mason, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2200 E Parrish Ave, Bldg B, Ste 101, Owensboro, KY 42303 Phone: 270-683-3232 Fax: 270-852-1600 |